Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis

J Am Acad Dermatol. 1996 Aug;35(2 Pt 1):199-201. doi: 10.1016/s0190-9622(96)90323-0.

Abstract

Background: Topical immunotherapy has been used in the treatment of children with alopecia areata with encouraging results.

Objective: Our purpose was to determine the long-term results in 33 children with severe alopecia areata treated with topical immunotherapy.

Methods: From 1983 to 1989 we treated 33 children with topical immunotherapy with squaric acid dibutylester.

Results: Complete hair regrowth was observed in 10 children (30.3%). During the follow-up period (mean, 5.9 years; range, 4 to 12 years), 7 of these 10 patients had severe relapses that were not responsive to further treatment. Only three clinically benefited from topical immunotherapy. Two maintained complete hair regrowth after treatment was stopped.

Conclusion: Our results indicate that only a small proportion of children with severe alopecia areata will obtain a persistent benefit from topical immunotherapy.

MeSH terms

  • Administration, Cutaneous
  • Adolescent
  • Allergens / administration & dosage
  • Allergens / therapeutic use*
  • Alopecia Areata / genetics
  • Alopecia Areata / therapy*
  • Autoantibodies / analysis
  • Child
  • Cyclobutanes / administration & dosage
  • Cyclobutanes / therapeutic use*
  • Female
  • Follow-Up Studies
  • Hair / drug effects
  • Hair / growth & development
  • Humans
  • Immunotherapy*
  • Male
  • Recurrence
  • Treatment Outcome

Substances

  • Allergens
  • Autoantibodies
  • Cyclobutanes
  • squaric acid dibutyl ester